HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 291/2/R335    most recent 00902.2005v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (4) Citing Articles via Google Scholar Google Scholar Articles by Chanda, M. L. Articles by Mogil, J. S. Search for Related Content PubMed PubMed Citation Articles by Chanda, M. L. Articles by Mogil, J. S.

CALL FOR PAPERS
Sex and gender differences in pain and inflammation

Sex differences in the effects of amiloride on formalin test nociception in mice

Department of Psychology and Centre for Research on Pain, McGill University, Montreal, Quebec, Canada

Submitted 21 December 2005 ; accepted in final form 23 March 2006

Amiloride is a nonspecific blocker of acid-sensing ion channels (ASICs) that have been recently implicated in the mediation of mechanical and chemical/inflammatory nociception. Preliminary data using a transgenic model are suggestive of sex differences in the role of ASICs. We report here that systemic administration of amiloride (10–70 mg/kg ip) produces a robust, dose-dependent blockade of late/tonic phase nociceptive behavior on the mouse formalin test (5%; 20 µl) in female but not male mice, completely abolishing the known sex difference in formalin test response. Adult gonadectomy produced a "switching" of sex differences in amiloride efficacy, with castrated males displaying an amiloride blockade and ovariectomized females rendered less sensitive to amiloride. Gonadectomized mice could be switched back to their intact status using chronic estrogen benzoate or testosterone propionate replacement via osmotic minipump (6 µg/day or 250 µg/day, respectively). It is unclear whether this striking sex difference is due to sex-specific involvement of ASICs in pain processing, but the present data represent one of the first demonstrations of pain-related sex differences with no obvious opioid involvement.

gonadectomy; hormone replacement

This article has been cited by other articles:

				K. J. Berkley, S. S. Zalcman, and V. R. Simon Sex and gender differences in pain and inflammation: a rapidly maturing field Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2006; 291(2): R241 - R244. [Full Text] [PDF]